Onconic Therapeutics Inc. (KOSDAQ:476060)
19,550
-2,800 (-12.53%)
Dec 30, 2025, 3:30 PM KST
397.77% (1Y)
| Market Cap | 994.35B |
| Revenue (ttm) | 46.65B |
| Net Income (ttm) | 16.75B |
| Shares Out | 44.49M |
| EPS (ttm) | 1,513.84 |
| PE Ratio | 14.76 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 3,589,443 |
| Average Volume | 4,357,898 |
| Open | 21,600 |
| Previous Close | 22,350 |
| Day's Range | 19,550 - 22,050 |
| 52-Week Range | 3,138 - 26,600 |
| Beta | n/a |
| RSI | 53.83 |
| Earnings Date | Mar 13, 2026 |